Alendronate Sodium, an aminobisphosphonate compound, has been effectively used for the treatment of osteolysis, Paget's disease and osteoporosis.
Synonyms: Alendronate sodium trihydrate; 4-amino-1-hydroxy-1-phosphonobutyl phosphonic acid, monosodium; MK-217
Molecular Formula: C4H12NaNO7P2 · 3 H2O
Molecular Weight: 325.12
Linear Structural Formula: C4H12NaNO7P2 · 3 H2O
MDL Number: MFCD01748233
Application: These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
Biochem Physiol Actions: Alendronate sodium trihydrate is a bone resorption inhibitor; farnesyl diphosphate synthase inhibitor (IC50 = 460 nM); CD45 protein tyrosine phosphatase inhibitor.
Other Notes: This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.